TC Biopharm (TCBP) Short Interest Ratio & Short Volume

$0.87

+0.01 (+1.16%)

(As of 07/26/2024 ET)

Compare

TC Biopharm Short Interest Data

Current Short Interest: 32,900 shares
Previous Short Interest: 14,300 shares
Change Vs. Previous Month: +130.07%
Dollar Volume Sold Short: $26,244.33
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 8,450,000 shares
Percentage of Shares Shorted: 0.39%
Today's Trading Volume: 41,791 shares
Average Trading Volume: 2,471,421 shares
Today's Volume Vs. Average: 2%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling TC Biopharm ?

Sign up to receive the latest short interest report for TC Biopharm and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

TCBP Short Interest Over Time

TCBP Days to Cover Over Time

TCBP Percentage of Float Shorted Over Time

Ad Colonial Metals

Collapse of the Petrodollar

The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.

In answer to this issue, we have released a Special Report to the public.

TC Biopharm Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	32,900 shares	$26,244.33	+130.1%	N/A	0	$0.80
6/30/2024	14,300 shares	$11,787.49	-42.6%	N/A	0	$0.82
6/15/2024	24,900 shares	$25,896.00	-56.6%	N/A	0	$1.04
5/31/2024	57,400 shares	$61,992.00	-56.3%	N/A	0	$1.08
5/15/2024	131,200 shares	$146,944.00	-30.1%	N/A	0	$1.12
4/30/2024	187,700 shares	$268,411.00	-21.0%	N/A	0	$1.43
Get the Latest News and Ratings for TCBP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TC Biopharm and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	237,600 shares	$311,256.00	+16.2%	N/A	0.1	$1.31
3/31/2024	204,500 shares	$267,895.00	-68.0%	N/A	0	$1.31
3/15/2024	638,700 shares	$1.07 million	+224.2%	N/A	0.2	$1.68
2/29/2024	197,000 shares	$250,190.00	-5.1%	N/A	0.1	$1.27
2/15/2024	207,500 shares	$213,725.00	+111.7%	N/A	0.3	$1.03
1/31/2024	98,000 shares	$106,820.00	+84.6%	N/A	0.1	$1.09
1/15/2024	53,100 shares	$135,405.00	+127.9%	N/A	0.4	$2.55
12/31/2023	23,300 shares	$73,861.00	-45.7%	N/A	0.2	$3.17
12/15/2023	42,900 shares	$110,682.00	-88.2%	N/A	0.6	$2.58
11/30/2023	364,400 shares	$134,062.76	+1,312.4%	N/A	0.5	$0.37
11/15/2023	25,800 shares	$13,274.10	-84.3%	N/A	0	$0.51
10/31/2023	164,000 shares	$70,520.00	-11.4%	N/A	0.5	$0.43
10/15/2023	185,000 shares	$68,746.00	+2,334.2%	N/A	0.5	$0.37
9/30/2023	7,600 shares	$3,268.00	-84.9%	N/A	0	$0.43
9/15/2023	50,400 shares	$23,698.08	+45.2%	N/A	0.1	$0.47
8/31/2023	34,700 shares	$19,432.00	-16.2%	N/A	0.1	$0.56
8/15/2023	41,400 shares	$22,219.38	-52.9%	N/A	0.1	$0.54
7/31/2023	87,900 shares	$54,498.00	-53.3%	N/A	0.1	$0.62
7/15/2023	188,100 shares	$96,582.95	-17.1%	N/A	0.4	$0.51
6/30/2023	226,900 shares	$122,979.80	-26.4%	N/A	0.4	$0.54
6/15/2023	308,100 shares	$188,526.39	+581.6%	N/A	1	$0.61
5/31/2023	45,200 shares	$36,734.04	-6.8%	N/A	0.2	$0.81
5/15/2023	48,500 shares	$36,326.50	-62.3%	N/A	0.2	$0.75
4/30/2023	128,500 shares	$142,635.00	+114.9%	N/A	0.4	$1.11
4/15/2023	59,800 shares	$83,122.00	-27.1%	N/A	0.1	$1.39
3/31/2023	82,000 shares	$131,200.00	+821.4%	N/A	0.1	$1.60
3/15/2023	8,900 shares	$32,841.00	-88.0%	N/A	0	$3.69
2/28/2023	74,100 shares	$312,702.00	+96.6%	N/A	0.1	$4.22
2/15/2023	37,700 shares	$262,015.00	-44.5%	N/A	0	$6.95
1/31/2023	67,900 shares	$347,648.00	-42.7%	N/A	0.1	$5.12
1/15/2023	118,400 shares	$530,432.00	+1,096.0%	N/A	0.2	$4.48
12/30/2022	9,900 shares	$38,115.00	+98.0%	N/A	0.2	$3.85
12/15/2022	5,000 shares	$21,150.00	-15.3%	N/A	0.3	$4.23
11/30/2022	5,900 shares	$27,789.00	+110.7%	N/A	0.4	$4.71
Dave Ramsey Makes Big Mistake Live On Air (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE
11/15/2022	2,800 shares	$23,800.00	-98.1%	N/A	0.2	$8.50
10/31/2022	148,500 shares	$25,987.50	+89.9%	N/A	0.7	$0.18
10/15/2022	78,200 shares	$17,243.10	-64.1%	N/A	0.2	$0.22
9/30/2022	217,600 shares	$61,036.80	-8.2%	N/A	0.6	$0.28
9/15/2022	236,900 shares	$77,016.19	+51.7%	N/A	0.6	$0.33
8/31/2022	156,200 shares	$51,217.98	-20.6%	N/A	0.3	$0.33
8/15/2022	196,800 shares	$83,167.68	+261.8%	N/A	0.2	$0.42
7/31/2022	54,400 shares	$19,616.64	-68.8%	N/A	0.1	$0.36
7/15/2022	174,600 shares	$69,228.90	No Change	N/A	0.2	$0.40

TCBP Short Interest - Frequently Asked Questions

What is TC Biopharm's current short interest?: Short interest is the volume of TC Biopharm shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 32,900 shares of TCBP short. Learn More on TC Biopharm's current short interest.
Is TC Biopharm's short interest increasing or decreasing?: TC Biopharm saw a increase in short interest in July. As of July 15th, there was short interest totaling 32,900 shares, an increase of 130.1% from the previous total of 14,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does TC Biopharm's short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TC Biopharm: OncoCyte Co. (2.46%), NRx Pharmaceuticals, Inc. (4.21%), MEI Pharma, Inc. (0.11%), Brainstorm Cell Therapeutics Inc. (1.54%), HCW Biologics Inc. (0.04%), Cara Therapeutics, Inc. (1.35%), TherapeuticsMD, Inc. (0.38%), JanOne Inc. (1.84%), Aptorum Group Limited (0.08%), VBI Vaccines Inc. (1.08%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

What does it mean to sell short TC Biopharm stock?: Short selling TCBP is an investing strategy that aims to generate trading profit from TC Biopharm as its price is falling. TCBP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against TC Biopharm?: A short squeeze for TC Biopharm occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCBP, which in turn drives the price of the stock up even further.
How often is TC Biopharm's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCBP, twice per month. The most recent reporting period available is July, 15 2024.